THE CODE: The Code is a three-part video series investigating the roots of today’s most promising genetic technologies
By Text: Sharon Begley Video: Retro Report,
STAT
| 04. 02. 2018
Those who do not remember the past are doomed to repeat it. And those who do not remember the sometimes irrational exuberance around past advances in biomedicine may be doomed to buy into the hype around today’s. From curing Alzheimer’s and Parkinson’s to eliminating cancer deaths, no goal has been too ambitious for the best minds in medicine to claim is within reach thanks to the latest scientific discovery.
Here is your genetic gut check.
This three-part series of documentary shorts, produced by Retro Report in partnership with STAT, looks back at the roots of three of today’s most promising genetic technologies: genetic testing to predict which diseases someone might develop, precision medicine to match people’s genes to the treatments most likely to work for them, and genome-editing via CRISPR to repair disease-causing genes. Watch and listen to experts explain how the 1980s and 1990s version of each was going to change medicine and save lives. It puts today’s promises in a whole new light.
PART 1

The race to sequence the human genome was also billed as a race...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...